Latest News

Uromedica Announces Successful First US Commercial Implant of ProACT™ Adjustable Continence Therapy for Men

November 2, 2017

Continue reading...


Uromedica Announces Launch of ProACT™ Adjustable Continence Therapy for Men with FDA Approval and Reimbursement Coding

July 11, 2017

Continue reading...


First patients enrolled in French Randomized Trial Between Uromedica’s Adjustable Continence Therapy (ACT) and Boston Scientific’s AMS 800 Artificial Urinary Sphincter (AUS)

July 4, 2016

Continue reading...


New ProACT Paper in Urology: Maximum Urethral Closure Pressure Increases After Successful Adjustable Continence Therapy (ProACT) for Stress Urinary Incontinence After Radical Prostatectomy

April 26, 2016

Continue reading…


ProACT Adjustable Continence Therapy for Men PMA Approved by USA Food and Drug Administration (FDA) 

November 24, 2015.

Continue reading…